These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15019536)

  • 1. Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis.
    Syvänne M; Whittall RA; Turpeinen U; Nieminen MS; Frick MH; Kesäniemi YA; Pasternack A; Humphries SE; Taskinen MR
    Atherosclerosis; 2004 Feb; 172(2):267-72. PubMed ID: 15019536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.
    Frick MH; Syvänne M; Nieminen MS; Kauma H; Majahalme S; Virtanen V; Kesäniemi YA; Pasternack A; Taskinen MR
    Circulation; 1997 Oct; 96(7):2137-43. PubMed ID: 9337181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.
    Syvänne M; Nieminen MS; Frick MH; Kauma H; Majahalme S; Virtanen V; Kesäniemi YA; Pasternack A; Ehnholm C; Taskinen MR
    Circulation; 1998 Nov; 98(19):1993-9. PubMed ID: 9808595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus.
    Genest J; Frohlich J; Steiner G
    Am J Cardiol; 2004 Apr; 93(7):848-53. PubMed ID: 15050487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2).
    Husemoen LL; Thomsen TF; Fenger M; Jørgensen HL; Jørgensen T
    Genet Epidemiol; 2003 May; 24(4):322-30. PubMed ID: 12687650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery disease, vascular syndrome x and healthy subjects.
    Soysal D; Savaş S; Susam I; Cevik C; Göldeli E; Sözmen E; Güneri S
    Anadolu Kardiyol Derg; 2003 Mar; 3(1):26-34, AXVIII-AXIX. PubMed ID: 12626307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total homocysteine, folate, and cobalamin, and their relation to genetic polymorphisms, lifestyle and body mass index in healthy children and adolescents.
    Huemer M; Vonblon K; Födinger M; Krumpholz R; Hubmann M; Ulmer H; Simma B
    Pediatr Res; 2006 Dec; 60(6):764-9. PubMed ID: 17065574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of T alleles and TT genotype at MTHFR 677C->T locus or C alleles and CC genotype at MTHFR 1298A->C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals.
    Ozarda Y; Sucu DK; Hizli B; Aslan D
    Cell Biochem Funct; 2009 Dec; 27(8):568-77. PubMed ID: 19764044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the C677T MTHFR polymorphism with homocysteine, ox-LDL levels, and thiolactonase activities in the severity of coronary syndrome.
    Koubaa N; Nakbi A; Hammami S; Mehri S; Attia N; Ben Farhat M; Hammami M
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):515-21. PubMed ID: 20530057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum folate, total homocysteine levels and methylenetetrahydrofolate reductase 677C>T polymorphism in young healthy female Japanese.
    Taguchi T; Mori H; Hamada A; Yamori Y; Mori M
    Asia Pac J Clin Nutr; 2012; 21(2):291-5. PubMed ID: 22507617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Myara A; Gerhardt M; Chevenne D; Trivin F; Farhat MB; Miled A; Maaroufi K
    Ann Clin Biochem; 2006 May; 43(Pt 3):200-6. PubMed ID: 16704755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease.
    Kölling K; Ndrepepa G; Koch W; Braun S; Mehilli J; Schömig A; Kastrati A
    Am J Cardiol; 2004 May; 93(10):1201-6. PubMed ID: 15135689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of genetic and environmental factors on plasma homocysteine concentrations in a population at high risk for coronary artery disease.
    Bowron A; Scott J; Stansbie D
    Ann Clin Biochem; 2005 Nov; 42(Pt 6):459-62. PubMed ID: 16259797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis.
    Spiroski I; Kedev S; Antov S; Arsov T; Krstevska M; Dzhekova-Stojkova S; Bosilkova G; Kostovska S; Trajkov D; Petlichkovski A; Strezova A; Efinska-Mladenovska O; Spiroski M
    Acta Biochim Pol; 2008; 55(3):587-94. PubMed ID: 18800176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine levels & 677C-->T methylenetetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity.
    Rassoul F; Richter V; Hentschel B; Geisel J; Herrmann W; Kuntze T
    Indian J Med Res; 2008 Feb; 127(2):154-8. PubMed ID: 18403793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C>T polymorphism.
    Mehlig K; Leander K; de Faire U; Nyberg F; Berg C; Rosengren A; Björck L; Zetterberg H; Blennow K; Tognon G; Torén K; Strandhagen E; Lissner L; Thelle D
    Heart; 2013 Dec; 99(23):1761-5. PubMed ID: 24014284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of total plasma homocysteine with methylenetetrahydrofolate reductase genotypes 677C>T, 1298A>C, and 1793G>A and the corresponding haplotypes in Swedish children and adolescents.
    Böttiger AK; Hurtig-Wennlöf A; Sjöström M; Yngve A; Nilsson TK
    Int J Mol Med; 2007 Apr; 19(4):659-65. PubMed ID: 17334642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography Trial.
    Syvänne M; Taskinen MR; Nieminen ; Manninen V; Kesäniemi YA; Pasternack A; Nawrocki JW; Haber H; Frick MH
    Control Clin Trials; 1997 Feb; 18(1):93-119. PubMed ID: 9055055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of the month. Usefulness of increasing HDL cholesterol in secondary prevention of coronary heart disease: results of the VA-HIT study].
    Scheen AJ
    Rev Med Liege; 1999 Sep; 54(9):773-5. PubMed ID: 10589275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.